Overview

Efficacy and Safety of Emodepside in Adults Infected With Hookworm

Status:
Not yet recruiting
Trial end date:
2022-12-12
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of emodepside to that of albendazole (Zentel®) in participants aged 18-60, inclusive, infected with hookworm.
Phase:
Phase 2
Details
Lead Sponsor:
Jennifer Keiser
Collaborator:
Public Health Laboratory Ivo de Carneri
Treatments:
Albendazole
Emodepside